Sudeep Pharma’s Rs 895 crore IPO opened today, following a robust anchor investor response and rising grey market premiums. The company, a specialty ingredients manufacturer, aims to capitalize on India’s expanding food and pharmaceutical markets. With strong financial performance and global reach, it presents a compelling long-term investment opportunity.